InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,230.00
(
-0.15%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,230.81
(
0.22%
)
Post# of 252300
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: DewDiligence post# 154150

Friday, 12/14/2012 7:30:47 PM

Friday, December 14, 2012 7:30:47 PM

Post# of 252300
I agree with Peter. The label will dissuade some oncologists from prescribing the drug second line.
I agree with you that the unrestricted label is more important commercially.
Correct me if I am wrong but, I thought a lot of people thought the drug would have more restrictions.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up